Home › Borstkanker › Maryland › Baltimore
Borstkanker klinische studies in Baltimore, MD
47 studies voor Borstkanker zoeken deelnemers op locaties in en rond Baltimore (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
RekruterenFase 3
- Mercy Medical Center, Baltimore
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- en nog 2
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekruterenFase 2
- Johns Hopkins University, Baltimore
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
RekruterenFase 3
- Maryland Proton Treatment Center, Baltimore
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
RekruterenFase 2
- Maryland Proton Treatment Center, Baltimore
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RekruterenFase 3
- Mercy Medical Center - Baltimore ( Site 0015), Baltimore
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
RekruterenFase 3
- Greenebaum Comprehensive Cancer Center ( Site 0036), Baltimore
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
RekruterenFase 3
- Clinical Trial Site, Baltimore
- Clinical Trial Site, Baltimore
- Clinical Trial Site, Annapolis · 22 mijl verwijderd
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RekruterenFase 1
- United Theranostics, Glen Burnie · 9 mijl verwijderd
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
RekruterenFase 2
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
RekruterenFase 3
- Saint Agnes Hospital, Clinical Research Center, Baltimore
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekruterenFase 3
- Mercy Medical Center, Baltimore
- Ascension St. Agnes Hospital, Baltimore
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
RekruterenFase 1/2
- Research Site, Baltimore
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
RekruterenFase 1/2
- Maryland Oncology Hematology - Annapolis, Annapolis · 22 mijl verwijderd
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
RekruterenFase 3
- Sidney Kimmel Comprehensive Cancer Center (SKCCC) at Johns Hopkins, Baltimore
Cardiometabolic Screening Program
Rekruteren
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC
RekruterenFase 2
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
RekruterenFase 3
- University of Maryland, Baltimore
- Velocity Clinical Research, Annapolis · 22 mijl verwijderd
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruterenFase 3
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Mercy Medical Center, Baltimore
- Greater Baltimore Medical Center, Baltimore
- en nog 8
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
RekruterenFase 2
- The Johns Hopkins Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine, Baltimore
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
RekruterenFase 3
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
RekruterenFase 2/3
- Local Institution - 1035, Baltimore
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
RekruterenFase 3
- Maryland Oncology Hematology, Annapolis · 22 mijl verwijderd
E-Mindfulness Approaches for Living After Breast Cancer
RekruterenFase 3
- Maryland Proton Treatment Center, Baltimore
- University of Maryland/Greenebaum Cancer Center, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- en nog 7
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RekruterenFase 2
- The John Hopkins Hospital, Baltimore
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
RekruterenFase 2
- Sidney Kimmel Comprehensive Cancer Center, Baltimore
EXoPERT EMERALD Clinical Study
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- John Hopkins University, Baltimore
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
RekruterenFase 3
- Johns Hopkins Kimmel Cancer Center, Baltimore
CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer
RekruterenFase 1
- Johns Hopkins University, Baltimore
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
RekruterenFase 1
- Advanced Molecular Imaging and Therapy, Glen Burnie · 9 mijl verwijderd
- United Theranostics - Chesapeake, Glen Burnie · 9 mijl verwijderd
Phase 1 Study of CLR 125 in Triple Negative Breast Cancer
RekruterenFase 1
- United Theranostics, Glen Burnie · 9 mijl verwijderd
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RekruterenFase 3
- Mfsmc-Hjwci, Baltimore
- Maryland Oncology Hematology P.A., Annapolis · 22 mijl verwijderd
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekruterenFase 3
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Greater Baltimore Medical Center, Baltimore
- Saint Agnes Hospital, Baltimore
- en nog 7
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekruterenObservatieonderzoek
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- UM Saint Joseph Medical Center, Towson · 8 mijl verwijderd
- en nog 1
The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer
Rekruteren
- Sidney Kimmel Comprehensive Cancer Center, the Avon Foundation Breast Center at Johns Hopkins, Baltimore
- Johns Hopkins Bayview, Baltimore
- Johns Hopkins Kimmel Cancer Center at Greenspring Station, Lutherville · 9 mijl verwijderd
GammaPod Dose Escalation Radiation for Early Stage Breast Cancer
Rekruteren
- UMMC, Baltimore
- Baltimore Washington Medical Center, Glen Burnie · 9 mijl verwijderd
- Upper Chesapeake Health, Bel Air · 22 mijl verwijderd
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RekruterenFase 1
- Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center, Baltimore
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
RekruterenObservatieonderzoek
- Weinberg Center at Mercy, Baltimore
- Greater Baltimore Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- en nog 3
Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors
Rekruteren
- Breast Evaluation and Treatment Program, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore
Study in Patients With Breast Cancer Leptomeningeal Metastasis
RekruterenObservatieonderzoek
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · 8 mijl verwijderd
The Cancer of the Pancreas Screening-5 CAPS5)Study
RekruterenFase 3
- Johns Hopkins Hospital, Baltimore
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
RekruterenFase 3
- UM Upper Chesapeake Medical Center, Bel Air · 22 mijl verwijderd
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
RekruterenObservatieonderzoek
- Mercy Medical Center, Baltimore
- Johns Hopkins Hospital, Baltimore
- Luminis Health Center for Cancer & Blood Disorders, Annapolis · 22 mijl verwijderd
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
RekruterenFase 2
- University of Maryland Medical Center (UMMC), Baltimore
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
RekruterenFase 1/2
- Johns Hopkins, Baltimore
First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies
RekruterenFase 1
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
Borstkanker studies in andere steden
- New York City, NY134 studies
- Houston, TX126 studies
- Boston, MA111 studies
- Nashville, TN80 studies
- Los Angeles, CA72 studies
- Edison, NJ68 studies
- St. Louis, MO64 studies
- Durham, NC63 studies
- Queens, NY63 studies
- Chicago, IL58 studies
- Philadelphia, PA56 studies
- Dallas, TX55 studies
Andere studies in Baltimore
- Niet-kleincellige longkanker60 studies
- Prostaatkanker43 studies
- Longkanker40 studies
- Kanker (alle vormen)37 studies
- Colorectale kanker31 studies
- Aldermeesklierkanker31 studies
- Metastatische kanker28 studies
- Obesitas25 studies
- Hartfalen24 studies
- Blasenkanker24 studies
- Beroerte22 studies
- Eierstokkanker22 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.